Trump administration considering UK COVID-19 vaccine before election
Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.
US coronavirus catastrophe: Who is to blame? | Head to Head [48:40]
The Trump administration is considering fast-tracking an experimental COVID-19 vaccine being developed by AstraZeneca Plc and Oxford University for use in the US ahead of the November 3 elections, the Financial Times reported.
One option being explored would involve the US Food and Drug Administration (FDA) awarding "emergency use authorization" in October to the potential vaccine, which was developed by Oxford and licensed to AstraZeneca, the FT reported.
|
Comments
Post a Comment